“Evaluating Fluoxetine’s Growth-Inhibitory Impact on Clinical Isolates of Enteric Bacteria: Harnessing Repurposing Potential”. Microbiological & Immunological Communications, vol. 2, no. 2, Dec. 2023, pp. 89-96, https://doi.org/10.55627/mic.002.02.0454.